Meropenem/vaborbactam activity against carbapenem-resistant Klebsiella pneumoniae from catheter-related bloodstream infections

QR Code

Meropenem/vaborbactam activity against carbapenem-resistant Klebsiella pneumoniae from catheter-related bloodstream infections

IntroductionCarbapenem-resistant Klebsiella pneumoniae (CRKP) poses a significant threat in oncology settings due to its multidrug resistance and ability to form biofilms on indwelling medical devices.MethodsThis study investigated the in vitro and in vivo activity of meropenem/vaborbactam (MEV) aga...

Full description

Saved in:

Bibliographic Details
Main Authors:	Francesca Sivori, Massimo Francalancia, Mauro Truglio, Ilaria Cavallo, Carmelina Pronesti, Giorgia Fabrizio, Ilaria Celesti, Andrea Cazzani, Lorenzo Furzi, Fulvia Pimpinelli, Enea Gino Di Domenico
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Cellular and Infection Microbiology
Subjects:	carbapenem-resistant Klebsiella pneumoniae multidrug-resistant plasmid meropenem/vaborbactam catheter-related bloodstream infections biofilm-associated infections surgical site infection
Online Access:	https://www.frontiersin.org/articles/10.3389/fcimb.2025.1616353/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Risk factors for vancomycin resistance in patients with Enterococcus faecium bloodstream infections: an analysis of the Munich Multicentric Enterococci Cohort
by: Laura Wagner, et al.
Published: (2025-07-01)

An analysis of risk factors for mortality in patients with bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae
by: ZHU Qiuli, et al.
Published: (2025-04-01)

Magnusiomyces capitatus bloodstream infection in a patient with acute monocytic leukemia: A rare case report
by: Tian Qi, et al.
Published: (2025-09-01)

Multidrug‐Resistant ESKAPEEc Pathogens From Bloodstream Infections in South Africa: A Cross‐Sectional Study Assessing Resistance to WHO AWaRe Antibiotics
by: Bakoena A. Hetsa, et al.
Published: (2025-06-01)

Influence of COVID-19 pandemic on the distribution and drug resistance of pathogens in patients with bloodstream infection
by: Yuanyuan Liu, et al.
Published: (2025-07-01)

DRESS syndrome on the background of adding meropenem to carbamazepine therapy: a clinical case
by: Yu. V. Ilina, et al.
Published: (2021-10-01)

Antibiotic sensitivity pattern in hemodialysis catheter (tunneled/non-tunneled)-related bloodstream infections at a tertiary care center in North India
by: Mohd Aslam, et al.
Published: (2025-04-01)

Trends in Antimicrobial Resistance of <i>Acinetobacter baumannii</i> and <i>Pseudomonas aeruginosa</i> from Bloodstream Infections: An Eight-Year Study in a Romanian Tertiary Hospital
by: Alina Maria Borcan, et al.
Published: (2025-06-01)

Risk factors for bloodstream infections in cardiac and neurosurgery patients
by: E. E. Sadovnikov, et al.
Published: (2025-03-01)

Antibiotic susceptibility pattern of Campylobacter sp. isolated from human stool samples including comparison of ellipsoid test and broth microdilution for meropenem
by: Fornefett, Juliane, et al.
Published: (2025-06-01)

Clinical Prediction of Secondary Bloodstream Infections in Patients with Cerebral Infarction: A Nomogram-Driven Risk Assessment Model Based on LASSO Regression
by: Zhang L, et al.
Published: (2025-07-01)

An integrated approach to the diagnosis of bacterial and fungal bloodstream infections in cancer patients
by: O. Yu. Kutsevalova, et al.
Published: (2020-11-01)

Successful management of a mediastinum abscess with sternum destruction caused by MSSA bloodstream infection
by: Hironobu Wada, et al.
Published: (2022-05-01)

The Effectiveness of the Combined Use of Meropenem and Avibactam Against Carbapenemase-Producing <i>Klebsiella pneumoniae</i> Strains in an <i>in vitro</i> Dynamic Model
by: E. N. Strukova, et al.
Published: (2025-04-01)

From access to reserve: antimicrobial resistance among etiological agents of central line-associated bloodstream infections in the view of WHO’s AWaRe antimicrobial spectrum
by: Anand, Gargee, et al.
Published: (2025-06-01)

Antibiotic treatment for 7 days versus 14 days in patients with uncomplicated bloodstream infections: a Systematic review and meta-analysis of randomized controlled trials and trial sequential analysis
by: Changyun Zhao, et al.
Published: (2025-08-01)

Bloodstream infections in different stage of reconstitution after first allogeneic hematopoietic stem cell transplantation
by: M. I. Akhmedov, et al.
Published: (2022-01-01)

Cefiderocol susceptibility of Stenotrophomonas maltophilia species complex and carbapenem-resistant Pseudomonas aeruginosa isolates from blood cultures at a university hospital in Tokyo, Japan
by: Wataru Aoki, et al.
Published: (2025-09-01)

Determination of Meropenem by Spectrophotometric-Application to Pharmaceutical Preparations
by: Nada A. Khalil, et al.
Published: (2020-02-01)

Burkholderia cenocepacia bacteremia in the oncology clinic: clinical features and outcomes
by: I. A. Kurmukov, et al.
Published: (2019-05-01)

Fundamental changes in the antimicrobial resistance profile of Klebsiella quasipneumoniae ATCC 700603 in response to meropenem stress
by: Mai H. Elmahdy, et al.
Published: (2025-06-01)

The prevalence, patterns, and antifungal drug resistance of bloodstream infection-causing fungi in Sichuan Province, China (2019–2023): a retrospective observational study using national monitoring data
by: Jin Deng, et al.
Published: (2025-07-01)

Epidemic Outbreak of Catheter-Associated Bloodstream Infections among Patients Receiving Renal Replacement Therapy
by: D. V. Kvashnina, et al.
Published: (2019-05-01)

Shorter versus longer-duration antibiotic treatments for immunocompetent patients with bloodstream infections: a systematic review and meta-analysisResearch in context
by: Ming Liu, et al.
Published: (2025-08-01)

Multi-omics profiling of cross-resistance between ceftazidime-avibactam and meropenem identifies common and strain-specific mechanisms in Pseudomonas aeruginosa clinical isolates
by: Bartosz J. Bartmanski, et al.
Published: (2025-07-01)

The Clinical Value of Systemic Immune Inflammatory Index in Predicting the Prognosis of Patients with Bloodstream Infection
by: Ou S, et al.
Published: (2025-07-01)

Clinical outcomes and safety of 7-day versus 14-day antibiotic therapy for bloodstream infections in adults: A systematic review and meta-analysis with trial sequential analysis
by: Chen-Wei Wu, et al.
Published: (2025-09-01)

Pharmacodynamics of meropenem and meropenem combined with avibactam against Klebsiella pneumoniae in an in vitro dynamic model
by: Strukova E.N., et al.
Published: (2025-03-01)

Initial Meropenem Plasma Concentration and Its Correlation with Sepsis Mortality: A Real-World Retrospective Study
by: Deng ZW, et al.
Published: (2025-08-01)

&beta;-Lactam/&beta;-Lactamase Inhibitor Combinations Non-Susceptible ESBL-Producing Enterobacteriaceae Bloodstream Infections: An Underestimated Clinical Entity
by: Zhang Y, et al.
Published: (2025-05-01)

In Vitro Evaluation of Antimicrobial Synergy Against Multidrug-Resistant Gram-Negative Paediatric Bloodstream Pathogens in South Africa
by: Prenika Jaglal, et al.
Published: (2025-06-01)

Biapenem Activity Against Meropenem-Resistant Klebsiella pneumoniae and Pseudomonas aeruginosa
by: E. M. Gordina, et al.
Published: (2022-08-01)

Risk of bloodstream infections in allogeneic hematopoietic cell transplant recipients according to gut mucosal colonization and fluoroquinolone implementation during neutropenia
by: G. A. Klyasova, et al.
Published: (2023-03-01)

Development and validation of a multidimensional predictive model for 28-day mortality in ICU patients with bloodstream infections: a cohort study
by: Jun Jin, et al.
Published: (2025-07-01)

Impact of tranexamic acid on the efficacy of vancomycin and meropenem against periprosthetic joint infections: an in vitro analysis
by: Liqin Yao, et al.
Published: (2025-07-01)

CLINICAL AND PHARMACOECONOMIC ANALYSIS OF CARBAPENEMS (MEROPENEM, IMIPENEM AND DORIPENEM) IN NOSOCOMIAL PNEUMONIA TREATMENT
by: I. I. Shteynberg, et al.
Published: (2015-03-01)

DETECTION OF MYCOBACTERIUM TUBERCULOSIS IN BLOOD FOR DIAGNOSIS OF GENERALISED TUBERCULOSIS IN HIV-POSITIVE PATIENTS
by: V. N. Zimina, et al.
Published: (2017-04-01)

Evolution of Resistant Mutants in <i>Pseudomonas aeruginosa</i> Persister Cells Under Meropenem Treatment
by: Jie Feng, et al.
Published: (2025-07-01)

Antimicrobial resistance of <i>Enterococcus faecium</i> and <i>Enterococcus faecalis</i>, isolated from blood culture of patients with hematological malignancies during different study periods
by: A. V. Fedorova, et al.
Published: (2021-04-01)

Pharmacokinetic analysis of meropenem therapeutic drug monitoring data (TDM) in critically ill adult patients
by: I. B. Bondareva, et al.
Published: (2022-03-01)